US2020385788A1PendingUtilityA1
Detection of Target Nucleic Acids in a Cellular Sample
Assignee: UNIV LELAND STANFORD JUNIORPriority: Oct 4, 2012Filed: May 13, 2020Published: Dec 10, 2020
Est. expiryOct 4, 2032(~6.2 yrs left)· nominal 20-yr term from priority
C12Q 1/6841C12Q 1/6813
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of assaying cells of a cellular sample for the presence of a target nucleic acid are provided. Aspects of the methods include evaluating a cellular sample that has been contacted with a nuclease inhibitor for the presence of a target nucleic acid. Also provided are devices and kits that find use in practicing the methods described herein.
Claims
exact text as granted — not AI-modified1 . A method of assaying a cellular sample for the presence of a target nucleic acid, the method comprising:
(i) contacting the cellular sample with a fixation reagent and a permeabilization reagent to produce a fixed/permeabilized cellular sample; (ii) contacting the fixed/permeabilized cellular sample with an aqueous post-fixation reagent to produce a rehydrated/fixed cellular sample; (iii) contacting the rehydrated/fixed cellular sample with a nuclease inhibitor; and (iv) evaluating the nuclease inhibitor-contacted rehydrated/fixed cellular sample for the presence of the target nucleic acid.
2 . The method according to claim 1 , wherein the target nucleic acid is a ribonucleic acid.
3 . The method according to claim 2 , wherein the ribonucleic acid is an mRNA, a microRNA, a fusion gene transcript, or a splice variant.
4 . The method according to claim 2 , wherein the nuclease inhibitor is an RNase inhibitor.
5 . The method according to claim 1 , wherein the method further comprises contacting the cellular sample with a protein detection reagent prior to step (i) and/or prior to step (iv).
6 . The method according to claim 5 , wherein the protein detection reagent comprises a labeled binding member that specifically binds to a target protein.
7 . The method according to claim 6 , wherein the labeled binding member comprises an antibody or binding fragment thereof.
8 . The method according to claim 6 , wherein the label is a metal.
9 . The method according to claim 6 , wherein the evaluating comprises measuring the amount of label using mass cytometry.
10 . The method according to claim 1 , wherein the evaluating comprises contacting the nuclease inhibitor-contacted rehydrated/fixed cellular sample with a nucleic acid detection agent.
11 . The method according to claim 10 , wherein the nucleic acid detection agent comprises a signal producing system comprising a labeled nucleic acid probe.
12 . The method according to claim 11 , wherein the label is a metal.
13 . The method according to claim 12 , wherein the evaluating comprises measuring the amount of label using mass cytometry.
14 . The method according to claim 11 , wherein the signal producing system comprises a signal amplification component.
15 . The method according to claim 14 , wherein the signal amplification component is a branched nucleic acid.
16 . The method according to claim 1 , wherein the evaluating comprises flow cytometrically analyzing the nuclease inhibitor-contacted rehydrated/fixed cellular sample.
17 . The method according to claim 1 , wherein the method comprises storing the nuclease inhibitor-contacted rehydrated/fixed cellular sample for a period of time prior to the evaluating step.
18 . The method according to claim 17 , wherein the nuclease inhibitor-contacted rehydrated/fixed cellular sample is stored in an aqueous buffer comprising a nuclease inhibitor.
19 . The method according to claim 18 , wherein the nuclease inhibitor-contacted rehydrated/fixed cellular sample is stored at a temperature below 0° C.
20 . The method according to claim 1 , wherein the cellular sample is contacted with a stimulating agent prior to contact with the fixation reagent.
21 .- 79 . (canceled)Join the waitlist — get patent alerts
Track US2020385788A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.